文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

脓毒性休克试验间无法解释的死亡率差异:人群特征与对照组死亡率的系统分析

Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates.
PubMed 文献 · Intensive Care Med · 2018-03-15
一句话结论65项脓毒性休克RCT的对照组死亡率总体38.6%,异质性I²=93%,仅约41%–42%可由纳入标准和基线特征解释。

该系统分析纳入2006至2018年发表的65项脓毒性休克随机对照试验,旨在识别与对照组死亡率试验间差异相关的纳入标准和基线特征。对照组总死亡率为38.6%,异质性显著(I²=93%,P<0.0001),95%预测区间13.5–71.7%。不同低血压、感染或血管加压药或机械通气纳入标准定义的试验间平均死亡率无差异。单变量与死亡率相关的因素包括平均SOFA评分(β=0.57,P=0.007)、平均血清肌酐(β=0.48,P=0.007)、机械通气患者比例(β=0.61,P<0.001)和使用血管加压药比例(β=0.57,P=0.002)。线性模型和递归分割所选人群特征组合分别解释了41%和42%的死亡率异质性。

要点

  • 65项脓毒性休克RCT对照组总死亡率38.6%,异质性I²=93%(P<0.0001),95%预测区间13.5–71.7%。
  • 不同低血压、感染、血管加压药或机械通气纳入标准定义的试验间平均死亡率无差异。
  • 单变量与死亡率相关的因素:平均SOFA评分(β=0.57,P=0.007)、平均血清肌酐(β=0.48,P=0.007)。
  • 机械通气患者比例(β=0.61,P<0.001)和使用血管加压药比例(β=0.57,P=0.002)单变量与死亡率相关。
  • 线性模型和递归分割所选人群特征组合分别解释了41%和42%的死亡率异质性。

适用人群与场景

  • 2006至2018年发表的脓毒性休克随机对照试验所纳入的患者。

研究设计与关键结果

  • 研究类型:系统分析,纳入65项脓毒性休克随机对照试验。
  • 对照组总死亡率为38.6%,异质性显著(I²=93%,P<0.0001),95%预测区间为13.5–71.7%。
  • 不同低血压、感染或血管加压药或机械通气纳入标准定义的试验间平均死亡率无差异。
  • 单变量与死亡率相关的因素:平均SOFA评分(标准化回归系数β=0.57,P=0.007)、平均血清肌酐(β=0.48,P=0.007)、机械通气患者比例(β=0.61,P<0.001)、使用血管加压药比例(β=0.57,P=0.002)。
  • 线性模型和递归分割所选人群特征组合分别解释了41%和42%的死亡率异质性。

证据类型、等级与局限

  • 证据类型:系统分析(系统综述)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

PURPOSE: Although the definition of septic shock has been standardized, some variation in mortality rates among clinical trials is expected. Insights into the sources of heterogeneity may influence the design and interpretation of septic shock studies. We set out to identify inclusion criteria and baseline characteristics associated with between-trial differences in control group mortality rates.

METHODS: We conducted a systematic review of RCTs published between 2006 and 2018 that included patients with septic shock. The percentage of variance in control-group mortality attributable to study heterogeneity rather than chance was measured by I2. The association between control-group mortality and population characteristics was estimated using linear mixed models and a recursive partitioning algorithm.

RESULTS: Sixty-five septic shock RCTs were included. Overall control-group mortality was 38.6%, with significant heterogeneity (I2 = 93%, P < 0.0001) and a 95% prediction interval of 13.5-71.7%. The mean mortality rate did not differ between trials with different definitions of hypotension, infection or vasopressor or mechanical ventilation inclusion criteria. Population characteristics univariately associated with mortality rates were mean Sequential Organ Failure Assessment score (standardized regression coefficient (β) = 0.57, P = 0.007), mean serum creatinine (β = 0.48, P = 0.007), the proportion of patients on mechanical ventilation (β = 0.61, P < 0.001), and the proportion with vasopressors (β = 0.57, P = 0.002). Combinations of population characteristics selected with a linear model and recursive partitioning explained 41 and 42%, respectively, of the heterogeneity in mortality rates.

CONCLUSIONS: Among 65 septic shock trials, there was a clinically relevant amount of heterogeneity in control group mortality rates which was explained only partly by differences in inclusion criteria and reported baseline characteristics.

来源:Intensive Care Med,查看原文。版权归原作者所有。

参考来源

  1. de Grooth HJ, Postema J, Loer SA, et al. Unexplained mortality differences between septic shock trials: a systematic analysis of population characteristics and control-group mortality rates. Intensive Care Med. 2018. PMID: 29546535. doi:10.1007/s00134-018-5134-8

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。